Advances in the Multidisciplinary Management of Hepatocellular Carcinoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 133
Special Issue Editors
Interests: liver surgery (liver cancer and benign liver conditions); pancreatic surgery (pancreatic cancer and benign pancreatic conditions); biliary and laparoscopic (keyhole) surgery
Special Issues, Collections and Topics in MDPI journals
Interests: liver; hepatitis; cancer therapy; hepatocellular carcinoma; oncology; surgery; cancer diagnostics; biliary tract diseases; surgical oncology; colorectal cancer
Special Issue Information
Dear Colleagues,
Hepatocellular carcinoma (HCC) is a disease that imposes a substantial burden, primarily affecting patients whom have underlying liver disease. In recent years, a plethora of novel systemic and local treatment options have emerged, significantly augmenting the complexity of patient management. Besides disease burden, factors such as patient fitness and liver function remain important in determining suitable treatment paths. Thus, decisions on the optimal, personalized treatment strategy are preferably made within the setting of a multidisciplinary team.
The objective of this Special Issue is to present a comprehensive overview of recent advances in the multidisciplinary management of HCC. In this Special Issue, original research articles and reviews are welcome. Research domains encompass, but are not confined to, hepatology, hepatobiliary surgery, transplant surgery, (interventional) radiology, and medical oncology.
Prof. Dr. Mohammed Abu Hilal
Dr. Timothy M. Pawlik
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- liver function
- prognosis
- systemic treatment
- local treatment
- resection
- trans-plantation
